An antibiotic may stop the recurrence of breast cancer.

Finding strategies to lower the likelihood that cancer will return or spread is one of the top concerns for cancer experts. According to a recent small-scale study, there may be a common, reasonably priced medication that accomplishes this. Tumor-initiating cells, or cancer stem cells (CSCs), are a popular subject among scientists. These cells contribute significantly to metastasis and recurrence, two of the major obstacles in cancer treatment, and are resistant to existing treatments. This is why there is a lot of interest in discovering effective methods for clearing up CSCs.